Sunday, March 29, 2026

BREAD OR BRICKS? : Why Kim Jong Un Is Spending Billions On Empty Skyscraper Shells While His People Starve

North Korea plans to build hundreds of thousands of housing units over five years, expanding on previous construction efforts.

Samsung Bioepis Secures U.S. Approval for Pen-Style Stelara Biosimilar, Setting a Market First

Samsung Bioepis receives FDA approval for Epyztek, the first pre-filled pen for autoimmune treatments, enhancing patient convenience.

Rice Cooker-Sized Tech, Big Strategic Ambitions in Low Earth Orbit

KARI has developed a cost-effective orbital deorbiting device for space debris removal, enhancing satellite reusability and sustainability.

Tag: Hanmi Pharmaceutical

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Hanmi Posts Record $1.16B Sales and $193M Operating Profit: What’s Driving the 2025 Surge

Hanmi Pharmaceutical reports record sales of $1.16 billion in January 2025, with significant growth in profits and new product launches.

FDA Grants Breakthrough Therapy Designation to Hanmi’s Epheglucagon: What This Means for Rare Disease Treatment

Hanmi Pharmaceutical's efpegerglucagon receives FDA Breakthrough Therapy designation for treating rare Congenital Hyperinsulinism, with Phase 2 results due soon.

How MiniRin and Nokdernah Are Revolutionizing Nocturia Care for Seniors: A Comprehensive Guide

Hanmi Pharmaceutical and Ferring Korea partner to distribute Minirin and Nocdurna for nocturia treatment, enhancing patient access.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.